Can moxibustion, an ancient treatment modality, be evaluated in a double-blind randomized controlled trial? - a narrative review.
10.1016/S2095-4964(14)60024-8
- Author:
Bai-Xiao ZHAO
1
;
Hai-Yong CHEN
2
;
Xue-Yong SHEN
3
;
Lixing LAO
4
;
E-mail: LXLAO1@HKU.HK.
Author Information
1. School of Acupuncture, Beijing University of Chinese Medicine, Beijing 100029, China.
2. School of Chinese Medicine, The University of Hong Kong, Hong Kong, China.
3. College of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
4. School of Chinese Medicine, The University of Hong Kong, Hong Kong, China
- Publication Type:Journal Article
- MeSH:
Double-Blind Method;
Humans;
Moxibustion;
Randomized Controlled Trials as Topic
- From:
Journal of Integrative Medicine
2014;12(3):131-134
- CountryChina
- Language:English
-
Abstract:
For thousands of years, moxibustion has been used for various diseases in China and other Asian countries. Despite the recent surge in Chinese herbal studies, few randomized controlled trials have been conducted on this modality, possibly due to the lacking of suitable double blinding methodology. This is a review of extant sham moxa devices and an introduction to a recently developed device that needs further validation.
